Pathophysiology and mediators of ischemia-reperfusion injury with special reference to cardiac surgery: A review

Scandinavian Cardiovascular Journal

Volumn 27, Issue S41, 1993, Pages 1-18

  Vaage, Jarle ^a   Valen, Guro ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Cardiac surgery; Coronary circulation; Inflammation; Ischemia; Mediators; Myocardial protection; Reperfusion; Stunning

Indexed keywords

ARACHIDONIC ACID; ENDOTHELIN; ENDOTHELIUM DERIVED RELAXING FACTOR; HISTAMINE; KININ; OXYGEN RADICAL; THROMBOCYTE ACTIVATING FACTOR;

CALCIUM HOMEOSTASIS; COMPLEMENT ACTIVATION; CONFERENCE PAPER; DIASTOLE; ENDOTHELIUM; FATTY ACID METABOLISM; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART SURGERY; LEUKOCYTE; LIPID METABOLISM; MEDIATOR; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; STUNNED HEART MUSCLE; SYSTOLE; THROMBOCYTE; ANIMAL; HUMAN; REVIEW;

ANIMALS; CARDIAC SURGICAL PROCEDURES; HUMANS; MYOCARDIAL REPERFUSION INJURY;

EID: 84907127180     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.3109/14017439309100154     Document Type: Article

References (210)

1. Effects of calcium chloride administration on the postischemic isolated rat heart
2. Is adenosine 5′-triphosphate derangement or free-radical-mediated injury the major cause of ventricular dysfunction during reperfusion? Role of adenine nucleotide transport in myocardial reperfusion injury
3. Mediation of cardiac ischemia by tromboxanes released from human platelets
4. Studies of controlled reperfusion after ischemia. XIII. Reperfusion conditions: Critical importance of total ventricular decompression during regional reperfusion
5. Studies of controlled reperfusion after ischemia. IX. Reperfusate composition: Benefits of marked hypocalcemia and diltiazem on regional recovery
6. Preserved high energy phosphate metabolic reserve in globally “stunned” hearts despite reduction of basal ATP content and contractility
7. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow
8. Calcium content of St. Thomas II cardioplegic solution damages ischemic immature myocardium
9. Delayed recovery of severely “stunned” myocardium with the support of a left ventricular assist device after coronary artery bypass surgery
10. Endothelial modulation of coronary tone
11. Enzymic conversion of rat liver xanthine oxidase from dehydrogenase (D-form) to oxidase (O-form)
12. Selective hypothermic cardiac arrest in normothermic animals
13. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins
14. Inhibition of platelet-activating factor fails to limit ischemia and reperfusion-induced myocardial damage
15. Revas-cularization of the right coronary artery: Influence on thermodilution right ventricular ejection fraction
16. Postischemic myocardial “stunning”: pathogenesis, pathophysiology, and clinical relevance
17. An accurate non-traumatic ultrasonic method to monitor myocardial wall thickening in patients undergoing cardiac surgery
18. Prolonged impairment of coronary vasodilation after reversible ischemia. Evidence for microvascular “stunning
19. Enhanced myocardial protection with verapamil prior to postischemic reflow
20. The determinants of myocardial oxygen consumption
21. Myocardial reperfusion: A double-edged sword?
22. Acute myocardial dysfunction and recovery: A common occurrence after coronary bypass surgery
23. The role of prostaglandins in the endothelium mediated vasodilatory response to hypoxia
24. Current problems in cardiac transplantation
25. Effects of bradykinin and Des-Arg-brady-kinin on the ischemic rat heart
26. Calcium and ischemic injury
27. Calcium entry blockers and cardioplegia: Interaction between nifedipine, potassium, and hypothermia
28. Accumulation of unesterified arachidonic acid in ischemic canine myocardium. Relationship to a phosphatidylcholine deacylation reacylation cycle and the depletion of membrane phospholipids
29. What is the contribution of altered lipid metabolism to arrhythmogenesis in the ischemic heart?
30. Amphipathic metabolites and membrane dysfunction in ischemicmyocardium
31. Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion
32. Cardiac dysfunction caused by purified human C3a anaphylatoxin
33. Coronary artery endothelial cell and smooth muscle dysfunction after global myocardial ischemia
34. Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury
35. Canine neutrophil activation by cardiac lymph obtained during reperfusion of ischemic myocardium
36. Effects of calcium channel blockers in coronary vasoconstriction induced by endothelin-1 in closed chest pigs
37. The effect of verapamil and other calcium antagonists on chemotoxis of polymorphonuclear leukocytes
38. Optimal conditions for reperfusion during cardiopulmonary bypass
39. Ischemia and reperfusion-induced formation of eicosanoids in isolated rat hearts
40. Complement-induced myocardial ischemia: Neutrophil and vascular mechanisms
41. Postischemic recovery in the stunned myocardium after reperfusion in the presence or absence of a flow-limiting coronary artery stenosis
42. Platelet deposition after surgically induced myocardial ischemia
43. Nifedipine as an adjunct to St. Thomas Hospital cardioplegia. A double-blind, placebo-controlled, randomized clinical trial
44. Endothelial and myocardial injury during ischemia and reperfusion: Pathogenesis and therapeutic implications
45. Reperfusion injury: Laboratory phenomenon or clinical reality?
46. Release of neuropeptide Y and noradrenaline from the human heart after aortic occlusion during coronary artery surgery
47. Mediator-induced activation of xanthine oxidase in endothelial cells
48. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
49. Myocardial protection and ischemia tolerance of the globally ischemic heart
50. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140
51. Arachidonic acid prostaglandin endoperoxide metabolism in isolated rabbit and coronary microvessels and isolated and cultivated coronary microvessel endothelial cells
52. Cardiac energetics
53. Myocardial thallium-201 kinetics and regional flow alterations with 3 hours of coronary occlusion and either rapid reperfusion through a totally patent vessel or slow reperfusion through a critical stenosis
54. Scintigraphic and hemodynamic demonstration of transient left ventricular dysfunction immediately after uncomplicated coronary artery bypass surgery
55. Myocardial and endothelial dysfunction after multiple, brief coronary occlusions: Role of oxygen radicals
56. Improved energy preservation following gentle reperfusion after hypothermic, ischemic cardioplegia in infarcted rat hearts
57. Subcellular calcium shifts in ischemia and reperfusion
58. Chemotactic activity in the coronary sinus after experimental myocardial infarction: Effects of pharmacologic interventions on ischemic injury
59. Reperfusion of the ischemic myocardium
60. Ischemia, reperfusion and the determinants of tissue injury
61. Stunning: A radical re-view
62. Reperfusion induced injury: Manifestation, mechanisms, and clinical relevance?
63. Ischemic contracture of the myocardium. Mechanism and prevention
64. Free radicals and calcium: Simultaneously acting triggers as determinants of vulnerability to reperfusion-induced arrhythmias in the rat heart
65. Nisoldipine inhibits lipid peroxidation induced by coronary occlusion in pig myocardium
66. Effect of intracoronary diltiazem on infarct size and regional myocardial function in the ischemic reperfused canine heart
67. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro
68. Reactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel
69. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart
70. Therapeutic ramifications of the interaction of complement, granulocytes, and platelets in the production of acute lung injury
71. Protection of cardiac membrane phospholipid against oxidative injury by calcium antagonists
72. Myocardial ischemia revisited: The osmolar load, membrane damage, and reperfusion
73. Preservation of coronary flow reserve in stunned myocardium
74. Endothelium and myocardial protecting actions of taprostene, a stable prostacyclin analogue, after acute myocardial ischemia and reperfusion in cats
75. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion
76. Injury to cultured endothelial cells by thrombin-stimulated platelets
77. Adenosine diphosphate-induced platelet aggregation and vascular injury in swine and rabbits
78. Adenosine diphosphate-induced platelet aggregation and myocardial infarction in Swine
79. Study of the mechanisms of hydrogen peroxide and hydoxyl free radical-induced cellular injury and calcium overload in cardiac myocytes
80. Membrane phospholipids and plasmalogens in the ischemic myocardium
81. Toxic properties of arachidonic acid on normal, ischemic and reperfused hearts. Indirect evidence for free radical involvement
82. Effect of antibody to leukocyte adhesion molecule CD 18 on recovery of neonatal lamb hearts after 2 hours of cold ischemia
83. Histaminergic modulation of coronary vascular resistance: Are we missing a therapeutic adjuvant for the treatment of myocardial ischemia?
84. Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium
85. Failure of iloprost to protect the regionally ischemic, reperfused porcine heart
86. The “no-reflow” phenomenon after temporary coronary occlusion in the dog
87. Consequences of ischemia-reperfusion on the coronary vasculature
88. Myocardial reperfusion injury. Platelet-activating factor stimulates leukocyte hydrogen peroxide production during myocardial reperfusion
89. PAF antagonists as potential therapeutic agents in cardiac anaphylaxis and myocardial ischemia
90. Temperature-specific effects of adjuvant diltiazem on myocardial energetics following potassium cardioplegic arrest
91. Modulation of PAF-induced leukocyte adherence and increased microvascular permeability
92. Reoxygenation-induced heart microvasculature endothelial cell injury and neutrophil hyperreaction: Role of arachidonate lipoxygenase metabolism
93. Evaluation of left ventricular systolic and diastolic dysfunction during transient myocardial ischemia produced by angioplasty
94. Detection of the terminal complement complex in patient plasma following acute myocardial infarction
95. Mechanisms of acute ischemic contractile failure of the heart
96. Endothelial dysfunction in myocardial ischemia and reperfusion: Role of oxygen-derived free radicals
97. Histamine in cardiovascular function and dysfunction: Recent developments
98. Ultrastructural changes in rat hearts following cold cardioplegic ischemia of different duration and different modes of reperfusion
99. Morphologic changes in atrial myocardial cells after cold cardioplegic standstill and during reperfusion in coronary bypass surgery
100. Endothelial cells of the cardiac microvasculature during and after cold cardioplegic ischemia. Comparison of endothelial and myocyte damage
101. Effect of ischemia and reperfusion on 125 I-endothelin binding in rat cardiac membranes
102. The harmful effect of ventricular distention during postischemic reperfusion
103. Endothelium-derived relaxing and contracting factors: Potential role in coronary artery disease
104. Endothelial control of vascular tone in large and small coronary arteries
105. Neutrophil mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery
106. Mechanism of calcium potentiation of oxygen free radical injury to renal mitochondria
107. Biventricular function after myocardial revascularization in humans: Deterioration and recovery patterns during the first 24 hours
108. Uptake, disposition and metabolism of histamine in isolated heart preparation
109. Reperfusion-induced arrhythmias: Mechanism and prevention
110. Reperfusion ventricular arrhythmias during intra-coronary thrombolysis
111. Pathogenetic role for calcium in stunning?
112. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion
113. Complement C5a decreases regional blood flow and myocardial function in pigs. Implications for a granulocyte mechanism
114. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury
115. Effects of H-receptor stimulation on coronary atrial diameter and coronary hemodynamics in humans
116. Impaired canine coronary vasodilator response to acetylcholine and bradykinin after occlusion-reperfusion
117. Nicardipine: Myocardial protection in isolated working hearts
118. Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction
119. Endogenous nitric oxide: Physiology, pathology and clinical relevance
120. Release of platelet activating factor from ischemic reperfused heart
121. Eicosanoids in myocardial ischemia reperfusion injury
122. The contribution of neutrophil activation and changes in endothelial function to myocardial ischemia-reperfusion injury
123. Late postoperative ventricular function after blood and crystalloid cardioplegia
124. Myocardial adenine pool depletion and recovery of mechanical function following ischemia
125. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size
126. Endothelin-1 and endothelin-3 induced vasorelaxation via common generation of endothelium-derived nitric oxide
127. Calcium antagonists and the “stunned” myocardium
128. Reperfusion injury: Laboratory artifact or clinical dilemma?
129. Calcium mediated damage during postischemic reperfusion
130. Decreased coronary flow reserve after transient myocardial ischemia in ischemia in dogs
131. Enhancement of cardiac prostacyclin release during reperfusion after diltiazem supplemented potassium cardioplegia
132. Studies of controlled reperfusion after ischemia. XIV. Reperfusion conditions: Importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion
133. Studies of controlled reperfusion after ischemia. VIII. Regional blood cardioplegic reperfusion during total vented bypass without thoracotomy. A new concept
134. 1 receptor stimulation on coronary artery diameter in patients with variant angina: Comparison with effect of acetylcholine
135. Reperfusion injury and its pharmacologic modification
136. Postischemic stunning—the case for calcium as the ultimate culprit
137. Myocardial stunning: A role for calcium antagonists during reperfusion?
138. Role of calcium ions in reperfusion arrhythmias: Relevance to pharmacologic intervention
139. Postischemic stunning: The two-phase model for the role of calcium as pathogen
140. Left ventricular diastolic function after coronary artery bypass grafting assessed by pulsed Doppler echocardiography
141. Hypoxia/reoxygenation stimulates endothelium to promote neutrophil adhesion
142. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils
143. Global myocardial ischemia and reperfusion impair endothelial—dependent relaxations to aggregating platelets in the canine coronary artery. A possible cause of vasospasm after cardiopulmonary bypass
144. Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries
145. Controlled versus hyperemic flow during reperfusion of jeopardized ischemic myocardium
146. Cumene hydroproxide induced changes in calcium homeostasis in cultured neonatal rat heart cells
147. Consumption of classical complement components by heart sub-cellular membranes in vitro and in patients after acute myocardial infarction
148. Complement localization and mediation of ischemic injury in baboon myocardium
149. Time course of recovery of “stunned” myocardium following variable periods of ischemia in conscious and anaesthetized does
150. Nifedipine administered after reperfusion ablates systolic contractile dysfunction of postischemic “stunned” myocardium
151. The hibernating myocardium
152. Asanguineous reperfusion in a canine model of cardiopulmonary bypass and controlled postischemic work
153. Sequential postoperative assessment of left ventricular performance with gated cardiac blood pool imaging following aortocoronary bypass surgery
154. Prolonged depletion of ATP and the adenine nucleotides following reversible myocardial ischemic injury in dogs
155. Early and long-term improvement in left ventricular performance following coronary bypass surgery
156. Serial assessment of left ventricular performance following coronary artery bypass grafting
157. Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improves protection during hypothermic ischemia
158. Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle
159. Mechanism of complement activation after coronary artery occlusion: Evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo
160. Influence of initial reperfusion pressure after hypothermic cardioplegic ischemia on endothelial modulation of coronary tone in neonatal lambs. Impaired coronary vasodilator response to acetylcholine
161. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium
162. Scintigraphic evidence of the “no reflow” phenomenon in human beings after coronary thrombolysis
163. The energetics of “stunned” myocardium
164. 2+ concentrations
165. Regulation of the mitochondrial ATP synthesis/ATPase complex
166. Granulocyte and eicosanoid gradients across the coronary circulation during myocardial reperfusion in cardiac surgery
167. Oxygen free radical producing leukocytes cause functional depression of isolated rat hearts: Role of leukotrienes
168. Coronary trapping of a complement activation product (C3a des-Arg) during myocardial reperfusion in open-heart surgery
169. Functional impairment in isolated rat hearts induced by activated leukocytes: Protective effect of oxygen free radical scavengers
170. Myocardial calcium and magnesium in acute ischemic injury
171. Activation of kinins in myocardial ischemia
172. Cardioprotection of organic nitric oxide donors in myocardial ischemia-reperfusion
173. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mol. anti-CD11b) that inhibits leukocyte adhesion
174. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro
175. Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia
176. Changes in left ventricular mechanical and hemodynamic function during acute rejection of the orthotopically transplanted heart in dogs
177. Biochemical basis for reperfusion arrhythmias
178. Heart preservation: Analysis of cardioprotective infusate characteristics. Membrane stabilization, calcium antagonists, and protease inhibition on myocardial viability: a biochemical, ultra-structural, functional study
179. Superoxide mediates reperfusion induced leukocyte-endothelial cell interactions
180. Effect of reperfusion temperature and pressure on the functional and metabolic recovery of preserved hearts
181. Prolonged myocardial nucleotide depletion after brief ischemia in the open-chest dog
182. Cardiac release of prostacyclin and thromboxane A2 during coronary revascularization
183. Diltiazem and the reduction of reperfusion-induced arrhythmias in the rat: Protection is secondary to modification of ischemic injury and heart rate
184. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat
185. Physiology of the transplanted heart
186. Reperfusion damage of the myocardium
187. Myocardial reperfusion injury: An inflammatory reaction
188. Toxic oxygen metabolites and ischemia-reperfusion increase histamine synthesis and release in the isolated rat heart
189. 2
190. The role of histamine in ischemia-reperfusion injury of isolated rat hearts
191. Toxic oxygen metabolites and leukocytes in reperfusion injury
192. Regulatory functions of the vascular endothelium
193. Reperfusion after acute coronary occlusion in dogs impair endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vivo
194. Endothelium-derived relaxing factor and coronary vasospasm
195. Time course of endothelial dysfunction and myocardial injury during coronary arterial occlusion
196. Studies of controlled reperfusion after ischemia. V. Superiority of surgical versus medical reperfusion after regional ischemia
197. Studies of controlled reperfusion after ischemia. VI. Metabolic and histochemical benefits of regional blood cardioplegic reperfusion without cardiopulmonary bypass
198. The effects of PAF antagonist on arrhythmias and platelets during acute myocardial ischemia and reperfusion
199. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats
200. Mechanisms of cardiovascular drugs as antioxidants
201. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat
202. Cardiac transplantation following storage of the donor heart by a portable hypothermic perfusion system
203. Effect of coronary occlusion during percutaneous transluminal angioplasty in humans on left ventricular chamber stiffness and regional diastolic pressure—radius relations
204. Prostacyclin rather than endogenous nitric oxide is a tissue protective factor in myocardial ischemia
205. Effect of staged versus sudden reperfusion after acute coronary occlusion in the dog
206. A novel potent constrictor peptide produced by vascular endothelial cells
207. Anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells
208. Morphologic changes of heart muscle caused by successive perfusion with calcium-free and calcium-containing solutions (calcium paradox)